{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:29:16Z","timestamp":1790490556743,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Clinicians face many challenges in disease stratification and outcome prediction in head and neck squamous cancer cell (HNSCC) patients. Given the limitations of currently used clinical scoring, repetitive biopsies, and imaging techniques, liquid biopsy approaches may provide valuable additional diagnostic and prognostic information.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>A noninterventional, single-center observational study was performed with clinical data and plasma samples from HNSCC patients. Cell-free tumor DNA-derived copy number aberrations (CNAs) were determined in 116 patients by low-coverage next-generation sequencing (NGS). Significant CNAs were combined in a genome-wide copy number instability score (CNI), which was evaluated with respect to conventional clinical staging and patient outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Receiver-operating characteristic (ROC) curve analysis comparing the presurgery CNI in patients (n = 103) with that in tumor-free controls (n = 142) yielded an area under the ROC curve of 87.2% (95% CI, 79.4%\u201393.3%). At a specificity of 95%, the sensitivity to detect tumors varied between 46% (pT1) and 94% (pT4). A CNI above the median (i.e., &amp;gt;72) had a positive predictive value of 90% (95% CI, 79%\u201396%) for lymph node involvement (LNI), while the negative predictive value was 57% (95% CI, 43%\u201370%). For a CNI &amp;gt;72, overall survival (OS) was worse (hazard ratio, 4.89; 95% CI, 1.39\u201317.17; P = 0.01) with 62% and 90% survivors 3 years after surgery for a CNI &amp;gt;72 and \u226472, respectively. In multivariable models, the CNI was a superior predictor of OS compared to established disease features, including LNI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The CNI may assist in predicting LNI and prognosis in HNSCC with direct therapeutic implications concerning the need for neck dissection or more aggressive treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2017.285668","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T14:25:13Z","timestamp":1523888713000},"page":"959-970","source":"Crossref","is-referenced-by-count":33,"title":["Cell-Free Plasma DNA for Disease Stratification and Prognosis in Head and Neck Cancer"],"prefix":"10.1093","volume":"64","author":[{"given":"Markus A","family":"Schirmer","sequence":"first","affiliation":[{"name":"Clinic of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Beck","sequence":"first","affiliation":[{"name":"Chronix Biomedical, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Leu","sequence":"first","affiliation":[{"name":"Clinic of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oellerich","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology, University Medical Center G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret","family":"Rave-Fr\u00e4nk","sequence":"first","affiliation":[{"name":"Clinic of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D","family":"Walson","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology, University Medical Center G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Sch\u00fctz","sequence":"first","affiliation":[{"name":"Chronix Biomedical, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Canis","sequence":"first","affiliation":[{"name":"Clinic of Otorhinolaryngology, Ludwig-Maximilian University of Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"2020022605554433600_B1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"2020022605554433600_B2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2015","journal-title":"Eur J Cancer"},{"key":"2020022605554433600_B3","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ejca.2015.07.043","article-title":"Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study","volume":"51","author":"Gatta","year":"2015","journal-title":"Eur J Cancer"},{"key":"2020022605554433600_B4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2020022605554433600_B5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","article-title":"Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment","volume":"91","author":"Marur","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2020022605554433600_B6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.oraloncology.2016.10.003","article-title":"Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"62","author":"Mermod","year":"2016","journal-title":"Oral Oncol"},{"key":"2020022605554433600_B7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00020840-200304000-00010","article-title":"Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma","volume":"11","author":"Puri","year":"2003","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2020022605554433600_B8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0284185113499326","article-title":"The prevalence of lymph node metastases in clinically N0 necks with oral cavity squamous cell carcinoma: is CT good enough for nodal staging?","volume":"55","author":"Furukawa","year":"2014","journal-title":"Acta Radiol"},{"key":"2020022605554433600_B9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hed.23689","article-title":"Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma","volume":"37","author":"Coskun","year":"2015","journal-title":"Head Neck"},{"key":"2020022605554433600_B10","first-page":"1832","article-title":"Development of a novel Markov chain model for the prediction of head and neck squamous cell carcinoma dissemination","volume":"2016","author":"Jung","year":"2017","journal-title":"AMIA Annu Symp Proc"},{"key":"2020022605554433600_B11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2020022605554433600_B12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2020022605554433600_B13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies","volume":"14","author":"Volik","year":"2016","journal-title":"Mol Cancer Res"},{"key":"2020022605554433600_B14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1373\/clinchem.2012.196014","article-title":"Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing","volume":"59","author":"Chan","year":"2013","journal-title":"Clin Chem"},{"key":"2020022605554433600_B15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1373\/clinchem.2014.226571","article-title":"Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer","volume":"61","author":"Sch\u00fctz","year":"2015","journal-title":"Clin Chem"},{"key":"2020022605554433600_B16","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/1078-0432.CCR-17-0231","article-title":"Tumor cell-free DNA copy number instability predicts therapeutic response to immunotherapy","volume":"23","author":"Weiss","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2020022605554433600_B17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2020022605554433600_B18","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2020022605554433600_B19","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1101\/gr.175141.114","article-title":"DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly","volume":"24","author":"Scheinin","year":"2014","journal-title":"Genome Res"},{"key":"2020022605554433600_B20","doi-asserted-by":"crossref","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"2020022605554433600_B21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2016.07.014","article-title":"The development of a liquid biopsy for head and neck cancers","volume":"61","author":"Schmidt","year":"2016","journal-title":"Oral Oncol"},{"key":"2020022605554433600_B22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000452861","article-title":"Liquid biopsy: a future tool for posttreatment surveillance in head and neck cancer?","volume":"84","author":"van Ginkel","year":"2017","journal-title":"Pathobiology"},{"key":"2020022605554433600_B23","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1373\/clinchem.2016.270207","article-title":"Free-circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients: an observational prospective cohort study","volume":"63","author":"Schr\u00f6ck","year":"2017","journal-title":"Clin Chem"},{"key":"2020022605554433600_B24","doi-asserted-by":"crossref","first-page":"293ra104","DOI":"10.1126\/scitranslmed.aaa8507","article-title":"Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas","volume":"7","author":"Wang","year":"2015","journal-title":"Sci Transl Med"},{"key":"2020022605554433600_B25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"key":"2020022605554433600_B26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of circulating tumor DNA to monitor metastatic breast cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N Engl J Med"},{"key":"2020022605554433600_B27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1373\/clinchem.2015.242453","article-title":"Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies","volume":"61","author":"Freidin","year":"2015","journal-title":"Clin Chem"},{"key":"2020022605554433600_B28","article-title":"Circulating tumor DNA as a \u2018liquid biopsy\u2019 in head and neck cancer. [Abstract]","author":"Perdomo","year":"2015"},{"key":"2020022605554433600_B29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/jnci\/djn125","article-title":"18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis","volume":"100","author":"Kyzas","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2020022605554433600_B30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/hed.24719","article-title":"Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer","volume":"39","author":"Rosko","year":"2017","journal-title":"Head Neck"},{"key":"2020022605554433600_B31","doi-asserted-by":"crossref","first-page":"e90360","DOI":"10.1371\/journal.pone.0090360","article-title":"Staging of cervical lymph nodes in oral squamous cell carcinoma: adding ultrasound in clinically lymph node negative patients may improve diagnostic work-up","volume":"9","author":"Norling","year":"2014","journal-title":"PLoS One"},{"key":"2020022605554433600_B32","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2003.02.006","article-title":"Quantification of free circulating DNA as a diagnostic marker in lung cancer","volume":"21","author":"Sozzi","year":"2003","journal-title":"J Clin Oncol"},{"key":"2020022605554433600_B33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1517\/14728222.2013.740012","article-title":"Matrix metalloproteinase-2 as a target for head and neck cancer therapy","volume":"17","author":"Chien","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"2020022605554433600_B34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hed.20365","article-title":"Matrix metalloproteases in head and neck cancer","volume":"28","author":"Rosenthal","year":"2006","journal-title":"Head Neck"},{"key":"2020022605554433600_B35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1593\/tlo.12172","article-title":"Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma","volume":"5","author":"Vogel","year":"2012","journal-title":"Transl Oncol"},{"key":"2020022605554433600_B36","volume-title":"TNM classification of malignant tumours","author":"Sobin","year":"2009","edition":"7th ed"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/6\/959\/32642014\/clinchem0959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/6\/959\/32642014\/clinchem0959.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T11:03:20Z","timestamp":1582715000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/64\/6\/959\/5608763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2017.285668","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6,1]]},"published":{"date-parts":[[2018,6,1]]}}}